Variant report
Variant | nsv1038515 |
---|---|
Chromosome Location | chr12:34217488-34257469 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78794228 | chr12:34250224-34250225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550944358 | chr12:34250231-34250232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569900116 | chr12:34250261-34250262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150065572 | chr12:34250299-34250300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532401584 | chr12:34250321-34250322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113712616 | chr12:34250346-34250347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183735241 | chr12:34250352-34250353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186959499 | chr12:34250360-34250361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565847915 | chr12:34250365-34250366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534733219 | chr12:34250366-34250367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554397966 | chr12:34250372-34250373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11053122 | chr12:34250376-34250377 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs536692899 | chr12:34250384-34250385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376356466 | chr12:34250407-34250408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543108993 | chr12:34250442-34250443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148718060 | chr12:34250454-34250455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553172200 | chr12:34250503-34250504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573129312 | chr12:34250541-34250542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576598985 | chr12:34250647-34250648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12814806 | chr12:34250648-34250649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575691057 | chr12:34250650-34250651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376921651 | chr12:34250672-34250673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114321411 | chr12:34250695-34250696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74075710 | chr12:34250735-34250736 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs532465313 | chr12:34250762-34250763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35440180 | chr12:34250767-34250768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191777524 | chr12:34250773-34250774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561352393 | chr12:34250775-34250776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184196516 | chr12:34250833-34250834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111954894 | chr12:34250849-34250850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548358399 | chr12:34250875-34250876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568062940 | chr12:34250876-34250877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531870151 | chr12:34250926-34250927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79091500 | chr12:34250931-34250932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570083873 | chr12:34250943-34250944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145259169 | chr12:34250947-34250948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553284701 | chr12:34250973-34250974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573190396 | chr12:34250974-34250975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535722266 | chr12:34250980-34250981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530301758 | chr12:34250991-34250992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1511547 | chr12:34251020-34251021 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs541099657 | chr12:34251037-34251038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111769857 | chr12:34251118-34251119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533036232 | chr12:34251119-34251120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544660462 | chr12:34251128-34251129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55917927 | chr12:34251146-34251147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533347341 | chr12:34251176-34251177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs56260627 | chr12:34251201-34251202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540619096 | chr12:34251207-34251208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190084559 | chr12:34251209-34251210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chordoma | 18071362 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:34250200-34250600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr12:34250400-34251200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr12:34251200-34251600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |